Dupixent 300 MG/2 ML syringe 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26F8E4N
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $19,817
Award facts
- Contract value 100% obligated
- $19,816.61 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $19,816.61 to Amerisourcebergen Drug Corp for the supply of Dupixent 300 mg/2 mL syringes. The award was issued on January 9, 2026, with an ultimate completion date of January 12, 2026, and represents a firm fixed-price contract with no set-aside designation. The place of performance is located in Conshohocken, Pennsylvania, where Amerisourcebergen Drug Corp maintains its corporate office. This delivery order falls under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999.999 billion through December 2026, which serves as a comprehensive pharmaceutical support vehicle enabling the company to supply a wide range of medications and medical supplies to support military healthcare programs worldwide.
Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. (doing business as Amerisourcebergen), is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement needs. The company was selected through competitive procurement to deliver Dupixent, a specialty pharmaceutical product used in the treatment of eczema and other inflammatory conditions, demonstrating the company's capability to fulfill federal requirements for brand-name medications. As a prime contractor under the DLA's pharmaceutical supply chain, Amerisourcebergen Drug Corp supports military treatment facilities, veterans' healthcare programs, and other federal medical institutions across multiple therapeutic domains, including specialty medications and medical devices.
Quick answers
Who was awarded contract SPE2DR26F8E4N?
SPE2DR26F8E4N was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 9, 2026.
How much is contract SPE2DR26F8E4N worth?
The government has obligated $19,817 on SPE2DR26F8E4N.
Is contract SPE2DR26F8E4N an order under another contract?
Yes. SPE2DR26F8E4N is a delivery order under SPE2DR25D3202, an indefinite delivery contract.
Was contract SPE2DR26F8E4N competed?
The extent of competition for SPE2DR26F8E4N was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award